参考文献/References:
[1] 刘明波,王增武,樊静,等. 《中国心血管健康与疾病报告2023》要点解读[J]. 中国心血管病研究,2024,22(7):577-593.
[2] Piepoli MF,Hoes AW,Agewall S,et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)[J]. Eur Heart J,2016,37(29):2315-2381.
[3] Ambrosetti M,Abreu A,Corrà U,et al. Secondary prevention through comprehensive cardiovascular rehabilitation:from knowledge to implementation. 2020 update. A position paper from the Secondary Prevention and Rehabilitation Section of the European Association of Preventive Cardiology[J]. Eur J Prev Cardiol,2021,28(5):460-495.
[4] 孙雪林,钱东方,张子轩,等. 国内外慢性非传染性疾病管理模式对比[J]. 中华老年医学杂志,2022,41(5):614-618.
[5] Phan P,Mitragotri S,Zhao ZM. Digital therapeutics in the clinic[J]. Bioeng Transl Med,2023,8(4):e10536.
[6] Patel NA,Butte AJ. Characteristics and challenges of the clinical pipeline of digital therapeutics[J]. NPJ Digit Med,2020,3(1):159.
[7] Nomura A. Digital health,digital medicine,and digital therapeutics in cardiology:current evidence and future perspective in Japan[J]. Hypertens Res,2023,46(9):2126-2134.
[8] Webb J,Peerbux S,Smittenaar P,et al. Preliminary outcomes of a digital therapeutic intervention for smoking cessation in adult smokers:randomized controlled trial[J]. JMIR Ment Health,2020,7(10):e22833.
[9] Noda Y,So R,Sonoda M,et al. The usefulness of a smartphone app-based smoking cessation program for conventional cigarette users,heated tobacco product users,and dual users:retrospective study[J]. J Med Internet Res,2023,25:e42776.
[10] Moravcová K,Karbanová M,Bretschneider MP,et al. Comparing digital therapeutic intervention with an intensive obesity management program:randomized controlled trial[J]. Nutrients,2022,14(10):2005.
[11] Aomori M,Matsumoto C,Takebayashi S,et al. Effects of a smartphone app-based diet and physical activity program for men living with HIV who have dyslipidemia:a pilot randomized controlled trial[J]. Jpn J Nurs Sci,2023,20(3):e12535.
[12] Kario K,Nomura A,Harada N,et al. Efficacy of a digital therapeutics system in the management of essential hypertension:the HERB-DH1 pivotal trial[J]. Eur Heart J,2021,42(40):4111-4122.
[13] 何霁云,赵丽明,刘凯. 数字疗法用于中国成人高血压患者进行自我管理的评估[J]. 心血管病学进展,2023,44(3):270-276.
[14] Kerr D,Ah D,Waki K,et al. Digital interventions for self-management of type 2 diabetes mellitus:systematic literature review and meta-analysis[J]. J Med Internet Res,2024,26:e55757.
[15] Agarwal P,Mukerji G,Desveaux L,et al. Mobile app for improved self-management of type 2 diabetes:multicenter pragmatic randomized controlled trial[J]. JMIR Mhealth Uhealth,2019,7(1):e10321.
[16] Morin CM. Profile of Somryst prescription digital therapeutic for chronic insomnia:overview of safety and efficacy[J]. Expert Rev Med Devices,2020,17(12):1239-1248.
[17] Forma F,Pratiwadi R,El-Moustaid F,et al. Network meta-analysis comparing the effectiveness of a prescription digital therapeutic for chronic insomnia to medications and face-to-face cognitive behavioral therapy in adults[J]. Curr Med Res Opin,2022,38(10):1727-1738.
[18] Hasan F,Tu YK,Yang CM,et al. Comparative efficacy of digital cognitive behavioral therapy for insomnia:a systematic review and network meta-analysis[J]. Sleep Med Rev,2022,61:101567.
[19] Venkatesan A,Rahimi L,Kaur M,et al. Digital cognitive behavior therapy intervention for depression and anxiety:retrospective study[J]. JMIR Ment Health,2020,7(8):e21304.
[20] Fundoiano-Hershcovitz Y,Asher IB,Ritholz MD,et al. Specifying the efficacy of digital therapeutic tools for depression and anxiety:retrospective,2-Cohort,real-world analysis[J]. J Med Internet Res,2023,25:e47350.
[21] Li YX,Gong YJ,Zheng B,et al. Effects on adherence to a mobile app-based self-management digital therapeutics among patients with coronary heart disease:pilot randomized controlled trial[J]. JMIR Mhealth Uhealth,2022,10(2):e32251.
[22] Dwiputra B,Santoso A,Purwowiyoto BS,et al. Smartphone-based cardiac rehabilitation program improves functional capacity in coronary heart disease patients:a systematic review and meta-analysis[J]. Glob Heart,2023,18(1):42.
[23] Des Roches CA,Balachandran I,Ascenso EM,et al. Effectiveness of an impairment-based individualized rehabilitation program using an iPad-based software platform[J]. Front Hum Neurosci,2015,8:1015.
[24] Chatterjee K,Buchanan A,Cottrell K,et al. Immersive virtual reality for the cognitive rehabilitation of stroke survivors[J]. IEEE Trans Neural Syst Rehabil Eng,2022,30:719-728.
[25] Grau-Pellicer M,Lalanza JF,Jovell-Fernández E,et al. Impact of mHealth technology on adherence to healthy PA after stroke:a randomized study[J]. Top Stroke Rehabil,2020,27(5):354-368.
[26] Zhang X,Luo ZRX,Yang MX,et al. Efficacy and safety of digital therapeutics-based cardiac rehabilitation in heart failure patients:a systematic review[J]. ESC Heart Fail,2022,9(6):3751-3760.
[27] Del Toro MR,Leano NHM,Barahona-Correa JE,et al. Effectiveness of mobile telemonitoring applications in heart failure patients:systematic review of literature and meta-analysis[J]. Heart Fail Rev,2023,28(2):431-452.
[28] Perez MV,Mahaffey KW,Hedlin H,et al. Large-scale assessment of a smartwatch to identify atrial fibrillation[J]. N Engl J Med,2019,381(20):1909-1917.
[29] Lubitz SA,Faranesh AZ,Selvaggi C,et al. Detection of atrial fibrillation in a large population using wearable devices:the Fitbit heart study[J]. Circulation,2022,146(19):1415-1424.
[30] Rizas KD,Freyer L,Sappler N,et al. Smartphone-based screening for atrial fibrillation:a pragmatic randomized clinical trial[J]. Nat Med,2022,28(9):1823-1830.
[31] Liu TY,Tang ZJ,Cai C,et al. Cost-effectiveness analysis of digital therapeutics for home-based cardiac rehabilitation for patients with atrial fibrillation after catheter ablation[J]. Digit Health,2023,9:20552076231211548.
[32] Sverdlov O,van Dam J,Hannesdottir K,et al. Digital therapeutics:an integral component of digital innovation in drug development[J]. Clin Pharmacol Ther,2018,104(1):72-80.
[33] 胡敏洁,陈明. 以元规制为基础的数字医疗法治建构[J]. 中国社会科学院大学学报,2022,42(6):66-82.
相似文献/References:
[1]白春兰,张军.正五聚蛋白-3:新型心血管病炎性标志物[J].心血管病学进展,2016,(1):87.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.023]
BAI Chunlan,ZHANG Jun.Pentraxin-3: A Novel Inflammation Biomarker for Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2016,(4):87.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.023]
[2]任茂佳,贺文帅,张琪,等.围绝经期对心血管疾病相关危险因素的影响[J].心血管病学进展,2019,(6):911.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.018]
REN Maojia,HE Wenshuai,ZHANG Qi,et al.Effects of Perimenopause on Cardiovascular Risk Factors[J].Advances in Cardiovascular Diseases,2019,(4):911.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.018]
[3]尹琳 黄从新.JP2蛋白和心血管疾病的研究进展[J].心血管病学进展,2019,(7):1004.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.010]
YIN Lin HUANG Congxin.Research Progress of JP2 Protein and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2019,(4):1004.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.010]
[4]朱峰 汪汉 蔡琳.抗体与心血管疾病[J].心血管病学进展,2019,(7):1007.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.011]
ZHU FengWANG HanCAI Lin.Antibodies and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2019,(4):1007.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.011]
[5]邱明仙 王正龙 许官学.心肌肌球蛋白结合蛋白-C磷酸化与心血管疾病关系的研究进展[J].心血管病学进展,2019,(7):1015.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.013]
QIU MingxianWANG ZhenglongXU Guanxue.Research Progress of the Relationship Between Cardiac Myosin Binding Protein-C and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2019,(4):1015.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.013]
[6]姬楠楠 杨晓静 谢勇.单核细胞/高密度脂蛋白比值与心血管疾病的研究进展[J].心血管病学进展,2019,(7):1019.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.014]
JI Nannan YANG Xiaojing XIE Yong.Monocyte/High-density Lipoprotein Ratio and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2019,(4):1019.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.014]
[7]渠海贤 李涛 程流泉.人工智能在心脏磁共振成像中的应用进展[J].心血管病学进展,2019,(5):659.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.001]
[8]侯冬华 郝丽荣.长正五聚蛋白3在动脉粥样硬化和心血管疾病中作用研究的新进展[J].心血管病学进展,2019,(5):805.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.035]
HOU Donghua H AO Lirong.The Study of Atherosclerosis and Cardiovascular Diseases with Pentapycin 3[J].Advances in Cardiovascular Diseases,2019,(4):805.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.035]
[9]张维 张恒 康品方.外泌体在心血管疾病中的研究进展[J].心血管病学进展,2019,(5):818.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.038]
Zhang WeiKang Pinfang.Exosome in Cardiovascular Diseases[J].Advances in Cardiovascular Diseases,2019,(4):818.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.038]
[10]韦莹 刘书旺 李蕾 崔鸣.生长分化因子-15在心房颤动中的研究进展[J].心血管病学进展,2019,(8):1073.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.001]
WEI Ying,LIU Shuwang,LI Lei,et al.Growth Differentiation Factor-15 in Development of Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2019,(4):1073.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.001]